Digital Diabetes Management Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, and Apps), By App (Digital Diabetes Management App and Weight & Diet Management App), By Device Type (Handheld Device and Wearable Device), By End-user (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, and Academic & Research Institutes) and Region Forecast 2020-2031

Digital Diabetes Management Market size was valued at US$ 23.4 billion in 2024 and is expected to reach US$ 44.4 billion by 2031, growing at a significant CAGR of 9.6% from 2025-2031. Patients can use the digital diabetes management system to improve self-management and control of their condition. One of the key obstacles in managing diabetes is lowering blood glucose levels and maintaining them, which drives up use of these systems. Digital involvement can help individuals with diabetes types 1 and 2 get the care they need. Diabetes monitoring hardware, mobile applications, and big data healthcare cloud computing infrastructure make up digital diabetes devices. The term "smart glucose monitor" refers to a wireless blood glucose monitor that measures and transmits blood glucose data to an iOS or Android mobile device.

The market is being driven by the availability of many apps on web-based app stores that can assist patients in monitoring their blood glucose levels, rising technical breakthroughs and innovations in the sector, and the global growth in diabetes prevalence. The ability of patients to address their health issues by connecting with their healthcare team and sharing data, as well as the growing demand for a digital ecosystem of data-driven tools that can connect patients and their care team for better diabetes management, are driving the growth of the market. The market is influenced by the increased acceptance of cloud-based enterprise solutions for diabetes management, the advent of digital platforms, the adoption of mobile apps for diabetes management, and the widespread usage of smartphones among consumers.

Furthermore, the market is influenced favourably by the growing elderly population, rising disease incidence, changing lifestyles and poor eating habits, rising obesity population, increased awareness, and increased healthcare spending. Strict regulations related to the approval of applications and devices, however, can impede market development. Stress, sedentary lifestyles, poor diets, and obesity are the main risk factors for diabetes. Physiological changes due to ageing are also a major contributor to the risk of diabetes.

For instance, the global population aged 60 and over grew from 962 million in 2017 to 1.9 billion in 2045, according to the World Population Aging Report 2017. Nevertheless, the prevalence of diabetes for people over the age of 60 in 2017 is 18.5%. The number of elderly people with diabetes is projected to grow to around 177.4 million in 2017 and to 337.8 million in 2045. The rising geriatric population, coupled with increasing population exposure to key risk factors, is therefore expected to drive demand across major markets for digital diabetes management solutions.  

Key Developments:

• In March 2024, Dexcom received FDA approval for its Stelo device, the first over-the-counter glucose biosensor. Designed for individuals with type 2 diabetes or prediabetes not using insulin, Stelo is a small wearable device that provides real-time glucose readings, empowering users to manage their health proactively.
• In November 2024, Medtronic announced FDA clearance for its InPen app, now featuring a missed meal dose detection. This enhancement is a step toward launching its Smart MDI system, integrated with the Simplera continuous glucose monitor (CGM).
• In April 2023, Insulet received FDA clearance for the Omnipod GO, an insulin delivery device tailored for individuals with type 2 diabetes aged 18 and older. This device offers a convenient alternative to daily long-acting insulin injections.